Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.

Also called NCT05544864

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 376 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05544864
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05544864. Randomized; no masking; primary purpose treatment. Start 2022-09-28 (actual); primary completion 2026-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
Acronym
ISAR-DESIRE5
Condition
Restenoses, Coronary
Intervention (Device)
Drug eluting stent (DES)
Intervention (Device)
Drug coated ballloon (DCB)
Lead sponsor
Deutsches Herzzentrum Muenchen (class: other)
Collaborator
EvidentIQ Germany GmbH (class: not stated)
Collaborator
Abbott (class: industry)
Collaborator
Technical University of Munich (class: other)

Record details

Record id
cardio:ct-nct05544864
Content hash
72b373242bdd3faa39c62ffe2c5b5bad2593649214d5b29318835b1fd0a7ea58